FIELD: medicine, ophthalmology, pharmacy. SUBSTANCE: invention proposes 0.2% chelepine D solution in 6% polyglucine in combination with chelepine D tablets. Drug shows antiviral and antiinflammatory total and local effect both at surface and deep keratitis forms combined with stroma damage. Drug can be used for treatment of patients with herpes-viral and adenoviral eye diseases. EFFECT: enhanced effectiveness of drug proposed. 1 cl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING ULCERATED HERPETIC KERATITIS | 1996 |
|
RU2122844C1 |
| METHOD FOR TREATING THE CASES OF ULCERATED HERPETIC KERATITIS | 2001 |
|
RU2192898C1 |
| ANTIHERPETIC AGENT | 1999 |
|
RU2164138C2 |
| METHOD FOR DETECTING INDICATIONS FOR INTERFERONOTHERAPY IN CASE OF OPHTHALMOHERPES | 2004 |
|
RU2258224C1 |
| MEDICINAL COMPOSITION FOR TREATMENT OF HERPETIC KERATITIS AND KERATOCONJUNCTIVITIS | 1995 |
|
RU2104002C1 |
| METHOD FOR CHOOSING PATHOGENETICALLY CAUSED THERAPEUTIC APPROACH TO VIRAL OCULAR DISEASES | 2012 |
|
RU2494741C1 |
| METHOD OF TREATMENT OF CORNEA ULCERS OF PSEUDOMONAS AND GONOCOCCAL AETIOLOGY | 2006 |
|
RU2330633C1 |
| METHOD OF SELECTING THERAPY OF CHRONIC INFLAMMATORY DISEASES OF EYE SURFACE BASED ON CONTROLLED POTENTIATION OF EXUDATIVE REACTION BY MEANS OF MECHANICAL OR IMMUNE IMPACT | 2009 |
|
RU2421193C2 |
| METHOD FOR TREATMENT OF HERPETIC KERATOUVEITIS | 0 |
|
SU1688885A1 |
| METHOD OF HERPETIC KERATITIS TREATMENT | 2007 |
|
RU2328252C1 |
